Big Pharma's Ails Could Spread To Biotech
Big Pharma’s Ails Could Spread To Biotech
It is no secret big drugmakers are sick. Investors should worry that their germs could spread to smaller, hotter biotech stocks.
Financial Snapshot For December
Financial Snapshot For December
Financial Snapshot For December 2004: Sideways
Biotech Foods Without the Fear Factor
Facing Biotech Foods Without the Fear Factor
“Almost everywhere food is sold these days, you are likely to find products claiming to contain no genetically modified substances. But unless you are buying wild mushrooms, game, berries or fish, that statement is untrue.”
Big Changes for Big Pharma
Big Changes for Big Pharma
Fallout from Vioxx and Celebrex will create plenty of pain in the sector. Here are six trends that will alter the industry in 2005
Biotechs forced to work harder to fill openings
Biotechs forced to work harder to fill openings:
Bay Area biotech companies are scrambling to attract and retain both researchers and executives in a cut-throat national and even international job market.
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments